v3.26.3
Investments in and Advances to Joint Ventures - Summary of Financial Information for Unconsolidated Joint Ventures (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Schedule Of Equity Method Investments [Line Items]          
Current assets $ 2,579,109   $ 2,579,109   $ 2,683,543
Total assets 5,985,237   5,985,237   5,769,534
Current liabilities 1,617,116   1,617,116   1,531,664
Total liabilities 3,237,080   3,237,080   3,001,862
Total joint venture equity 2,637,648   2,637,648   2,642,020
Investments in and advances to unconsolidated joint ventures 174,764   174,764   148,640
Revenue 1,650,548 $ 1,621,748 4,717,591 $ 4,760,431  
Costs 1,268,481 1,261,893 3,682,866 3,698,240  
Net income attributable to Parsons Corporation 54,153 64,123 91,860 185,556  
Equity in earnings of unconsolidated joint ventures 7,242 8,266 (20,350) 6,937  
Unconsolidated Joint Ventures          
Schedule Of Equity Method Investments [Line Items]          
Current assets 1,373,495   1,373,495   1,549,367
Noncurrent assets 411,609   411,609   439,496
Total assets 1,785,104   1,785,104   1,988,863
Current liabilities 843,237   843,237   1,046,970
Noncurrent liabilities 458,554   458,554   469,833
Total liabilities 1,301,791   1,301,791   1,516,803
Total joint venture equity 483,313   483,313   472,060
Investments in and advances to unconsolidated joint ventures 174,764   174,764   $ 148,640
Revenue 599,294 608,305 1,331,238 1,558,656  
Costs 551,887 563,832 1,318,855 1,476,009  
Net income attributable to Parsons Corporation 47,407 44,473 12,383 82,647  
Unconsolidated Joint Ventures          
Schedule Of Equity Method Investments [Line Items]          
Equity in earnings of unconsolidated joint ventures $ 7,242 $ 8,266 $ (20,350) $ 6,937